Product Assortment
| Product Image | Cat/NHRIC Number | Product Size | Gel Pad Size | Suggested Devices | Same Size/ Shape as other Tegaderm™ SKU | HCPCS Code |
| 1657 NHRIC 8333-1657-01 |
3 1/2 in x 4 1/2 in 8,5 cm x 11,5 cm |
1 1/2 in x 1 3/8 in 3 cm x 4 cm |
All CVCs, Arterial, Dialysis, Midline, Other percutaneous devices | 1655 | A6257 | |
|
||||||
| 1658 NHRIC 8333-1658-01 |
4 in x 4 3/4 in 10 cm x 12 cm |
1 1/2 in x 1 3/8 in 3 cm x 4 cm |
Universal, Other percutaneous devices | 1616 | A6257 | |
|
||||||
| 1659 NHRIC 8333-1659-01 |
4 in x 6 1/8 in 10 cm x 15,5 cm |
1 1/2 in x 2 4/5 in 3 cm x 7 cm |
All CVCs, PICC | 1650 | A6258 | |
|
||||||
| 1660 NHRIC 8333-1660-01 |
2 3/4 in x 3 3/8 in 7 cm x 8,5 cm |
4/5 in x 4/5 in 2 cm x 2 cm |
All CVCs, Arterial, Midline, Other percutaneous devices | —— | A6257 | |
|
||||||
Overview
Tegaderm™ CHG Dressings combine the antimicrobial power of CHG with the simplicity, reliability and dependability of a Tegaderm™ brand dressing. This integrated, one-step CHG and transparent dressing helps to improve compliance to facility protocol. The intuitive design is clinician-friendly and the ease-of-application minimizes opportunity for error. The CHG antimicrobial cannot be applied incorrectly or forgotten.
Transparent Film
- Serves as a barrier to organisms, including those most commonly associated with CRBSIs
- Allows continuous site observation
- Conforms to body contours, flexes with patient movement and supports varied insertion practices
- Semi-permeable, breathable, allows good moisture vapor exchange
CHG Gel Pad
- Unique composition of water, polymers and 2% chlorhexidine gluconate
- CHG is immediately and continuously available, does not require additional moisture
- The absorptive CHG gel pad protects even in the presence of blood, saline and exudate.
Sterile Tape Strips
- Gel pad conforms around catheter, helping provide catheter securement
- Unique adhesive properties of gel pad help stabilize the catheter, minimizing catheter movement
- Unique dressing design with deep notch helps reduce dressing lift caused by the weight of the catheter and tubing
Catheter Securement
- Gel pad conforms around catheter, helping provide catheter securement
- Unique adhesive properties of gel pad help stabilize the catheter, minimizing catheter movement
- Unique dressing design with deep notch helps reduce dressing lift caused by the weight of the catheter and tubing
Soft Cloth Border
- Reinforced borders and notches help to reduce edge lift and create a better seal around the catheter
- Provides comfort and durability
- Intuitive design is clinician-friendly; ease-of-application minimizes opportunity for error
Suggested Application
- Peripheral and midline venous catheters
- Central venous catheters (including subclavian, jugular, femoral and PICCs)
- Dialysis catheters
- Pulmonary artery catheters
- Arterial catheters
- Epidural catheters
- Other percutaneous devices
Transparency Enables Continuos Visual Inpsection
3M™ Tegaderm™ CHG Dressings integrate the powerful antimicrobial effectiveness of CHG with the transparency, simplicity and reliability of a Tegaderm™ brand dressing to support best practices and protocols.
Older technologies, like CHG impregnated sponge disks applied under a transparent film dressing, cover the insertion site, not allowing clinicians’ site visibility.
Tegaderm™ CHG Dressings are transparent, allowing continuous site observation, as recommended by both the Centers for Disease Control and Prevention (CDC) and the Infusion Nursing Standards of Practice (2008).
Integrated Product Helps Improve Compliance and Reduces Cost
Integrated 3M™ Tegaderm™ CHG Dessings have process built in, helping improve consistency and compliance to protocol in one single step. The intuitive design takes the guesswork out of application, minimizes the opportunity for error and ensures CHG is applied correctly.
Reduced Training Time
In a survey of infection preventionists released by the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC), when asked to identify the greatest challenges to implementing best practices to prevent CRBSIs,* one of the top two answers was educating staff. Because the CHG gel pad is integrated with the transparent film, nurses do not have to learn or remember any additional steps in the process of applying Tegaderm™ CHG Dressings. The ease-of-application can help reduce training time and increase productivity.
Seven in 10 feel they do not have enough time to train others adequately on how to prevent bloodstream infections.
Reduced Training Expenses
The costs for training and retraining staff can be significant. An inhouse evaluation at Floating Hospital for Children at Tufts Medical Center demonstrated significant cost savings could be realized because Tegaderm™ CHG Dressings are intuitive to apply, easy to use, and require less training.
The Use of Chlorhexidine Gluconate (CHG) on Central Line Insertion Sites: Disc vs. Gel Pad Dressing
100% of nurses reported they were ALWAYS able to place the Tegaderm™ CHG Dressings correctly.
Only 8% of nurses reported they were ALWAYS able to place the BIOPATCH® Disk correctly.
Reduced Inventory Management
You can reduce the number of SKUs your facility has to purchase and stock. Tegaderm™ CHG Dressings integrate CHG protection and transparent dressing into one reliable product, eliminating the need to purchase CHG-impregnated sponge disks in addition to transparent film dressings.
*3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs.
BIOPATCH® is a registered trademark of ETHICON, INC.
The Risks and Costs of Catheter-Related Infections
3M™ Tegaderm™ CHG Dressings are the only transparent IV site dressings integrated with a CHG gel pad proven to reduce skin flora,† a leading cause of costly, non-reimbursed CRBSIs.*
Costs to PatientsIncreased health complications and decreased ability to work or perform daily activities An estimated 12%-25% of patients who get a CRBSI will die1 Financial and emotional stress as a result of the death of a family member |
Costs to the Facility$34,508–$56,000—estimated cost per bloodstream infection2,3 Remunerative or punitive measures for “Never Events" Diminished reputation of the facility/system and stigma of public reporting of CRBSIs |
Costs to SocietyAn estimated 30,000 patient deaths annually attributed to CRBSIs4 Healthcare costs associated with treatment will likely exceed $2 billion this year4 |
In the last three decades, the number of bloodstream infections has nearly tripled in the U.S., with central venous catheters (CVCs) accounting for up to 90% of all catheter-related bloodstream infections (CRBSIs).5 CRBSIs are one of the most costly and deadly infections transmitted in healthcare facilities. CRBSIs can lead to increased costs associated with extended hospital stays, illness and death.
One of the major risk factors contributing to CRBSIs is skin organisms (flora) at the catheter insertion site.6 The CDC recommends the use of products containing CHG as one of the top five performance strategies found to be successful in reducing CRBSIs.4
The Centers for Medicare and Medicaid Services (CMS) considers CRBSIs to be ‘Never Events’ which are defined as “adverse events that are serious, largely preventable, and of concern to both the public and health care providers for the purpose of public accountability.” Several states have enacted laws requiring the disclosure of Never Events at hospitals and various remunerative or punitive measures for such events. CMS no longer reimburses for hospital-acquired CRBSIs, and other Never Events, and many private insurers are now following suit. Increasing media attention to hospital infections has raised public awareness of CRBSIs.
Learn more about CRBSIs, infection prevention, and 3M Health Care’s role in helping to minimize infection:
Infection Prevention in the United States Backgrounder
Catheter-Related Bloodstream Infections in the United States Backgrounder
3M Health Care: Minimizing the Risk of Infection for More than 30 Years
Clinical Evidence
Reduces Skin Flora
Reduces Skin Flora
| Shown to be better than BIOPATCH® at reducing skin flora on healthy adult subjects for up to 10 days | |
Suppresses Regrowth
Proven more effective than BIOPATCH® at preventing regrowth of skin flora on healthy adult subjects at day 7. |
|
|
Tegaderm™ CHG Dressings maintained significantly lower counts than BIOPATCH® or control dressings after 7 days on healthy adult subjects. |
Provides Continuous Protection
|
The reservoir of CHG within the gel pad was as available and as effective at Day 10 as Day 1.
|
See all of the evidence for yourself.
3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs. BIOPATCH® is a registered trademark of ETHICON, INC.
|
Performs Better
Rated Better Overall
|
Tegaderm™ CHG Dressings were rated significantly better compared to BIOPATCH® in:
|
IV Nurses Would Switch
|
IV nurses would recommend switching from BIOPATCH® to Tegaderm™ CHG Dressings:
|
Better Securement
|
Clinicians said Tegaderm™ CHG Dressings made their work easier and faster while at the same time providing quality. Rated significantly better for their ability to mold and conform around the catheter. |
See all of the evidence for yourself.
|
3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs. BIOPATCH® is a registered trademark of ETHICON, INC.
|
Protects Better
Broad-spectrum Antimicrobial Activity
|
Tegaderm™ CHG Dressing serves as a barrier against organisms including those most commonly associated with CRBSIs.* |
Effective Against Most Common Pathogens Causing CRBSIs
|
Unique size, shape and composition bathes insertion site with CHG and provides a greater zone of inhibition. |
|
CHG Migrates Under the Catheter
|
Provides continuous antimicrobial protection, even under the catheter. |
See all of the evidence for yourself.
|
3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs. BIOPATCH® is a registered trademark of ETHICON, INC.
|
Supports Best Practices and Protocols
Transparent Dressings
|
The CDC and the INS recommend transparent dressings because they allow continuous site observation. CDC/HICPAC Guidelines for the Prevention of Intravascular Catheter-Related Infections (2002) “Transparent dressings reliably secure the device, permit continuous visual inspection of the catheter site...and require less frequent changes than do standard gauze and tape dressings; the use of these dressings saves personnel time.” The Infusion Nursing Standards of Practice (2008) Standard 51.2: “Catheter site care shall allow for observation and evaluation of the catheter-skin junction and surrounding tissue.” Standard 56, Infection Practice, Criteria E: “Catheter insertion sites should be observed for redness, edema, induration, temperature changes and drainage.” |
CHG-Impregnated Dressings
|
The SHEA Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals, for the first time, recommends the use of a chlorhexidine-impregnated sponge dressing for the prevention of CRBSIs. |
Supports Existing Protocols
|
Research has shown Tegaderm™ CHG Dressings are easy to use and fit into clinical practice as easily as standard Tegaderm™ brand transparent dressings. The integrated, one-step CHG and transparent dressings help to improve compliance to facility protocol. The intuitive design is clinician-friendly and easy-of-application minimizes opportunity for error. The CHG antimicrobial cannot be applied incorrectly or forgotten. “Our nursing staff loves Tegaderm™ CHG for its simplicity. You simply can’t forget a step in the application process like you can with other dressings that require a separate CHG patch.” Pat Catadul, Pediatric Vascular Access Nurse, Boston, MA |
See all of the evidence for yourself.
|
3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs. BIOPATCH® is a registered trademark of ETHICON, INC.
|
Downloads
Authors - Eyberg C‚ 3M Clinical Research, et al.
Published/Presented - Journal of the Association for Vascular Access (JAVA)
Date - Fall‚ 2008
Download Antimicrobial Activity of a CHG-Impregnated Gel Pad for IV Site Protection
Authors - Schwab D‚ 3M Senior Research Microbiologist, et al.
Published/Presented - Infusion Nursing Society (INS)
Date - May‚ 2008
Download Economic Evaluation of Antimicrobial IV Dressings
Authors - Brenner J, MBA‚ 3M Health Care
Published/Presented - Infusion Nursing Society (INS)
Date - May‚ 2009
Download Evaluation of a New CHG Gel Pad Dressing for Catheter Care
Authors - Zehrer C, RN, MS, 3M Clinical Research, et al.
Published/Presented - Infusion Nursing Society (INS)
Date - May‚ 2009
Authors - Meninger S, RN, BSN, Floating Hospital for Children at Tufts Medical Center, et al.
Published/Presented - Association for Vascular Access (AVA)
Date - September, 2009
Download Study of Bloodsteam Infection Rates: Factors You Should Know
Authors - Walters S., MS, 3M Health Care, et al.
Published/Presented - Association for Vascular Access (AVA)
Date - September, 2009
Professional Standards & Guidelines
Education
Application & removal videos | Application & Removal Photos | Professional Resources
Application & Removal Videos
Application & Removal Photos
3M™ Tegaderm™ CHG Dressing 1657
Click a thumbnail for a larger image. |
Tegaderm™ CHG Dressings come in multiple shapes and sizes, supporting a variety of catheter sites and insertion practices.
Professional Resources
Association for Vascular Access (AVA)
AVA is the leading multidisciplinary vascular access organization comprised of committed professionals. Nurses, pharmacists, physicians, and vascular access industry representatives have all discovered the value of professional excellence, education, and networking opportunities available through AVA membership.
PEDIVAN - A virtual network of pediatric vascular access clinicians, educators, and manufacturers
Centers for Disease Control and Prevention (CDC)
For over 60 years, the CDC has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. They are committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people.
Infusion Nurses Society (INS)
INS is committed to bringing innovative new resources and opportunities to a wide range of healthcare professionals who are involved with the specialty practice of infusion therapy. In this new world of rapid technological advances and dramatic shifts in healthcare delivery, INS is setting the standard for dedicated clinicians who seek to provide excellent infusion care across all practice settings.
Infusion Nursing Standards of Practice (2008)
